Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daisuke Ito

Showing results (461-470 of 490) with videos related to

Pageof 49
Sort By:
Cancer Immunology Research|November 19, 2016
Eradication of Canine Diffuse Large B-Cell Lymphoma in a Murine Xenograft Model with CD47 Blockade and Anti-CD20Kipp Weiskopf, Katie L Anderson, Daisuke Ito, et al.
Alzheimer'S Research & Therapy|November 21, 2024
Can the clinical sign "head-turning sign" and simple questions in "Neucop-Q" predict amyloid β pathology?Yugaku Daté, Shogyoku Bun, Keisuke Takahata, et al.
Neurology|September 29, 2022
Impact of Amyloid and Tau PET on Changes in Diagnosis and Patient ManagementSho Shimohama, Toshiki Tezuka, Keisuke Takahata, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2012
Elevation of Sema4A implicates Th cell skewing and the efficacy of IFN-β therapy in multiple sclerosisYuji Nakatsuji, Tatsusada Okuno, Masayuki Moriya, et al.
Scientific Reports|October 21, 2016
Plasmodium vivax GPI-anchored micronemal antigen (PvGAMA) binds human erythrocytes independent of Duffy antigen statusYang Cheng, Feng Lu, Bo Wang, et al.
Scientific Reports|May 12, 2016
LRRK1 is critical in the regulation of B-cell responses and CARMA1-dependent NF-κB activationKeiko Morimoto, Yoshihiro Baba, Hisaaki Shinohara, et al.
Future Oncology (London, England)|January 5, 2026
Safety and efficacy of preoperative chemotherapy for obstructive colon cancer with endoscopic stenting: SUCCEED studyRyosuke Mizuno, Rei Mizuno, Ryosuke Okamura, et al.
JCI Insight|June 11, 2026
Fatty acid amide hydrolase inhibition for treatment of amyotrophic lateral sclerosisDaisuke Ito, Madoka Iida, Yohei Iguchi, et al.
Molecular Cancer Therapeutics|October 24, 2022
ER-851, a Novel Selective Inhibitor of AXL, Overcomes Resistance to Antimitotic DrugsShuntaro Tsukamoto, Naoko Hata Sugi, Kyoko Nishibata, et al.
Cell Stem Cell|June 2, 2023
Phase 1/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discoverySatoru Morimoto, Shinichi Takahashi, Daisuke Ito, et al.
Pageof 49

Showing results (461-470 of 490) with videos related to

Sort By:
Pageof 49
Cancer Immunology Research|November 19, 2016
Eradication of Canine Diffuse Large B-Cell Lymphoma in a Murine Xenograft Model with CD47 Blockade and Anti-CD20Kipp Weiskopf, Katie L Anderson, Daisuke Ito, et al.
Alzheimer'S Research & Therapy|November 21, 2024
Can the clinical sign "head-turning sign" and simple questions in "Neucop-Q" predict amyloid β pathology?Yugaku Daté, Shogyoku Bun, Keisuke Takahata, et al.
Neurology|September 29, 2022
Impact of Amyloid and Tau PET on Changes in Diagnosis and Patient ManagementSho Shimohama, Toshiki Tezuka, Keisuke Takahata, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2012
Elevation of Sema4A implicates Th cell skewing and the efficacy of IFN-β therapy in multiple sclerosisYuji Nakatsuji, Tatsusada Okuno, Masayuki Moriya, et al.
Scientific Reports|October 21, 2016
Plasmodium vivax GPI-anchored micronemal antigen (PvGAMA) binds human erythrocytes independent of Duffy antigen statusYang Cheng, Feng Lu, Bo Wang, et al.
Scientific Reports|May 12, 2016
LRRK1 is critical in the regulation of B-cell responses and CARMA1-dependent NF-κB activationKeiko Morimoto, Yoshihiro Baba, Hisaaki Shinohara, et al.
Future Oncology (London, England)|January 5, 2026
Safety and efficacy of preoperative chemotherapy for obstructive colon cancer with endoscopic stenting: SUCCEED studyRyosuke Mizuno, Rei Mizuno, Ryosuke Okamura, et al.
JCI Insight|June 11, 2026
Fatty acid amide hydrolase inhibition for treatment of amyotrophic lateral sclerosisDaisuke Ito, Madoka Iida, Yohei Iguchi, et al.
Molecular Cancer Therapeutics|October 24, 2022
ER-851, a Novel Selective Inhibitor of AXL, Overcomes Resistance to Antimitotic DrugsShuntaro Tsukamoto, Naoko Hata Sugi, Kyoko Nishibata, et al.
Cell Stem Cell|June 2, 2023
Phase 1/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discoverySatoru Morimoto, Shinichi Takahashi, Daisuke Ito, et al.
Pageof 49